Get started
Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

CDTX trade ideas

Trade Setup Summary:CDTX🟢 Trade Type: Long Ticker: CDTX Timeframe: 30-Min Chart Pattern: Breakout from an ascending wedge (bullish continuation) 📈 Entry Point: Around $25.50 Confirmed breakout from the wedge pattern 🔒 Stop-Loss: Below $24.25 Just under the wedge support and last consolidation zone 🎯 Take Profit Target: TP1: $27.24 (first resistance level) TP2: $29.72 (major resistance zone / target zone) 📊 Risk-Reward Ratio: Reward: ~$4.22 Risk: ~$1.25 R:R ≈ 3.3:1 (very favorable) 🔎 Technical Highlights: Strong bullish momentum with high volume Clean breakout from wedge and resistance zones 22% gain intraday confirms strong buyer interest
NASDAQ:CDTXLong
by ProfittoPath
Cidara (CDTX) Develops Next-Gen Immunotherapy TreatmentsCidara Therapeutics, Inc. (CDTX) is a biotechnology company focused on developing long-acting anti-infectives and immunotherapies. Its lead product, rezafungin, targets serious fungal infections, while its Cloudbreak® platform is designed to treat and prevent viral diseases. With growing global demand for innovative anti-infective solutions, CDTX is gaining attention for its targeted approach to unmet medical needs. On the chart, CDTX recently formed a confirmation bar with rising volume and moved above the .236 Fibonacci level, entering the momentum zone. This signals increased interest from traders and potential for further upside. The .236 level can serve as a trailing stop reference using the Fibonacci snap tool to help manage risk while capturing additional gains.
NASDAQ:CDTXLong
by traderspro_charts
$CDTX can rise in the next daysContextual immersion trading strategy idea. Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases The demand for shares of the company looks higher than the supply. Due to the spread of COVID-19, the demand for the company`s services rose. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2,82; stop-loss — $2,59. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:CDTXLong
by KozakHlib